What We Know About the Behavioral Effects and Risks of Synthetic Cannabinoids ("Spice")

Scientific research on synthetic cannabinoids is still in early stages, but available evidence indicates these compounds carry significant abuse potential, tolerance, dependence, withdrawal, and toxicity risks that often exceed THC.

Järbe, Torbjörn U C et al.·Current topics in behavioral neurosciences·2017·Moderate EvidenceReview
RTHC-01413ReviewModerate Evidence2017RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

This review consolidated the scientific literature on "Spice" compounds, synthetic cannabinoids originally designed as research tools that became widely abused recreational drugs.

In behavioral assays comparing synthetic cannabinoids to THC, the synthetic compounds generally produced similar effects but often at greater potency or with additional toxicity. Studies documented abuse liability (animals will self-administer these compounds), rapid tolerance development, physical dependence, and withdrawal symptoms.

The review emphasized that these compounds were never intended for human consumption and that scientifically based information about their toxicity and long-term behavioral effects is extremely limited. Most safety data comes from emergency department reports and case series rather than controlled studies.

Methodological challenges include the constant appearance of new compounds, variable composition of street products, and difficulties administering these compounds in controlled research settings.

Key Numbers

The review covers multiple synthetic cannabinoid compounds but does not provide pooled statistics. It notes the "fairly recent" nature of recreational use and the nascent state of preclinical research.

How They Did This

Literature review consolidating published behavioral studies of synthetic cannabinoids in both animals and humans, comparing effects to THC. Covers abuse liability, tolerance, dependence, withdrawal, and toxicity data.

Why This Research Matters

Synthetic cannabinoids remain a significant public health threat, particularly among populations without access to regulated cannabis and those subject to drug testing. This review highlights how little is actually known about compounds that thousands of people have consumed.

The Bigger Picture

The synthetic cannabinoid phenomenon illustrates what happens when prohibition drives users toward unregulated alternatives. The compounds are generally more potent and more dangerous than the natural product they were designed to mimic, creating a paradox where drug policy intended to reduce harm may have increased it.

What This Study Doesn't Tell Us

Much of the evidence comes from anecdotal reports and case series rather than controlled studies. The rapid turnover of compounds on the market means research is always behind the current products. Most preclinical studies focus on a small number of compounds that may not represent the full range of products available.

Questions This Raises

  • ?How can research keep pace with the constantly evolving synthetic cannabinoid market?
  • ?Would legal access to regulated cannabis reduce synthetic cannabinoid use?
  • ?Are there long-term neurological effects from synthetic cannabinoid use that have not yet been identified?

Trust & Context

Key Stat:
Synthetic cannabinoids were never intended for human use and research is still in early stages
Evidence Grade:
Literature review covering animal and human behavioral data. Moderate because it synthesizes legitimate evidence but the underlying research base is limited and rapidly evolving.
Study Age:
Published in 2017.
Original Title:
Tripping with Synthetic Cannabinoids ("Spice"): Anecdotal and Experimental Observations in Animals and Man.
Published In:
Current topics in behavioral neurosciences, 32, 263-281 (2017)
Database ID:
RTHC-01413

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

Are synthetic cannabinoids more dangerous than marijuana?

Available evidence suggests yes. Synthetic cannabinoids generally produce similar effects to THC but at greater potency, with additional toxicity risks. They were never designed for human consumption and their long-term effects are largely unknown.

Can you get addicted to synthetic cannabinoids?

Research shows synthetic cannabinoids carry abuse liability (animals will self-administer them), and users can develop tolerance, physical dependence, and experience withdrawal symptoms, similar to but potentially more severe than with natural cannabis.

Read More on RethinkTHC

Cite This Study

RTHC-01413·https://rethinkthc.com/research/RTHC-01413

APA

Järbe, Torbjörn U C; Raghav, Jimit Girish. (2017). Tripping with Synthetic Cannabinoids ("Spice"): Anecdotal and Experimental Observations in Animals and Man.. Current topics in behavioral neurosciences, 32, 263-281. https://doi.org/10.1007/7854_2016_16

MLA

Järbe, Torbjörn U C, et al. "Tripping with Synthetic Cannabinoids ("Spice"): Anecdotal and Experimental Observations in Animals and Man.." Current topics in behavioral neurosciences, 2017. https://doi.org/10.1007/7854_2016_16

RethinkTHC

RethinkTHC Research Database. "Tripping with Synthetic Cannabinoids ("Spice"): Anecdotal an..." RTHC-01413. Retrieved from https://rethinkthc.com/research/jarbe-2017-tripping-with-synthetic-cannabinoids

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.